苦参碱对哇巴因诱导钠电流改变的调节作用

目的:探讨苦参碱拮抗哇巴因诱导的心律失常的作用机制。方法:应用全细胞膜片钳技术记录哇巴因对单个豚鼠心室肌细胞的Na+电流和动作电位时程作用后,观察苦参碱对哇巴因诱导Na+电流和动作电位时程改变的恢复作用。结果:1 5μmol·L-1哇巴因延长APD50从给药前476±40.7 ms增加到744±62.9 ms(n=6,P0.05),APD90从给药前499±84.9 ms增加到775±87.7 ms(n=6,P0.01),100μmol·L-1苦参碱恢复APD50至603±79.0 ms(n=6,P0.05),APD90至630±81.6 ms(n=6,P0.05);2 5μmol·L-1哇巴因可增加钠电流的峰值,在-20 m V电压条件下,5μmol·L-1哇巴因增加INa,由正常-40.9±2.32 p A/p F增加到-55.2±2.26 p A/p F(n=8,P0.05),100μmol·L-1苦参碱减少INa至-34.6±2.14 p A/p F(n=8,P0.05);5μmol·L-1哇巴因右移钠通道的激活曲线,并左移钠通道的失活曲线从而改变通道动力学特性;100μmol·L-1苦参碱可抑制哇巴因诱导的INa的增加,并恢复Na+通道动力学特性接近正常。结论:苦参碱拮抗哇巴因诱导的心律失常机制与其抑制哇巴因诱发细胞水平Na+电流的增加,缩短哇巴因诱发APD的延长有关。     

苦参碱对大鼠宫颈癌组织中Survivin、Caspase-3和Caspase-7表达的影响

目的:探讨苦参碱对宫颈癌模型大鼠组织中Survivin、Caspase-3和Caspase-7的表达影响。方法:选取Wistar雌性大鼠34只,宫颈癌造模成功的19只分成阴性对照组(A组)和苦参碱组(B组);未造模的10只大鼠作为正常对照组(C组)。采用免疫印迹法检测三组大鼠宫颈癌组织中Survivin、Caspase-3和Caspase-7表达水平。结果:1A组大鼠组织中Survivin表达明显高于B、C组大鼠组织中Survivin水平,差异有统计学意义(P0.05);2A组大鼠组织中Caspase-3和Caspase-7的表达明显低于B、C组,差异有统计学意义(P0.05);3B组大鼠组织中Survivin、Caspase-3和Caspase-7的表达水平与C组比较存在差异,差异有统计学意义(P0.05)。结论:苦参碱能够明显下调宫颈癌大鼠凋亡抑制因子Survivin水平,改善凋亡因子Caspase-3和Caspase-7的表达。     

苦参碱注射液对急性病毒性心肌炎的治疗作用

目的：观察苦参碱注射液治疗急性病毒性心肌炎（AVM）的临床疗效。方法：将AVM患者120例随机分为治疗组63例及对照组57例,对照组采用常规疗法,治疗组在对照组基础上给予苦参碱注射液治疗,连用2周。观察临床疗效。结果：治疗组总有效率90.5%,对照组总有效率73.7%,两组比较有显著性差异。治疗组治疗后血清肌酸磷酸激酶（CPK）、天冬氨酸转氨酶（AST）及血清乳酸脱氢酶（LDH）较对照组治疗后明显降低,差异有统计学意义（P〈0.05）。结论：苦参碱对急性心肌炎有良好疗效。     

苦参碱注射液对急性病毒性心肌炎的治疗作用

目的:观察苦参碱注射液治疗急性病毒性心肌炎(AVM)的临床疗效.方法:将AVM患者120例随机分为治疗组63例及对照组57例,对照组采用常规疗法,治疗组在对照组基础上给予苦参碱注射液治疗,连用2周.观察临床疗效.结果:治疗组总有效率90.5%,对照组总有效率73.7%,两组比较有显著性差异.治疗组治疗后血清肌酸磷酸激酶(CPK)、天冬氨酸转氨酶(AST)及血清乳酸脱氢酶(LDH)较对照组治疗后明显降低,差异有统计学意义(P＜0.05).结论:苦参碱对急性心肌炎有良好疗效.     

苦参活性成分的抗肿瘤作用机制研究进展

苦参是中国传统的植物药,具有清热燥湿等多种作用,广泛地应用于抗肿瘤研究,其活性成分能够通过细胞周期阻滞抑制肿瘤细胞的增殖、诱导肿瘤细胞分化、通过细胞周期阻滞、Fas/Fasl和线粒体途径诱导肿瘤细胞凋亡,通过降低VEGF等的表达抑制肿瘤血管生成和内皮细胞增殖,抑制肿瘤侵袭和转移,通过抑制端粒酶活性、逆转多药耐药、调节免疫耐受等辅助治疗肿瘤。通过收集、分析和整理最近几年涉及苦参活性成分抗肿瘤作用的文献,综述其抗肿瘤作用机制,为临床应用苦参治疗肿瘤提供参考。     

Design,synthesis and biological evaluation of matrine derivatives as potential anticancer agents

Using matrine (1) as the lead compound, a series of new 14-(N-substituted-2-pyrrolemethylene) matrine and 14-(N-substituted-indolemethylene) matrine derivatives was designed and synthesized for their potential application as anticancer agents. The structure of these compounds was characterized by ¹H NMR, ¹³C NMR and ESI-MS spectral analyses. The target compounds were evaluated for their in vitro cytotoxicity against three human cancer cell lines (SMMC-7721, A549 and CNE2). The results revealed that compound A6 and B21 displayed the most significant anticancer activity against three cancer cell lines with IC₅₀ values in range of 3.42–8.05?μM, which showed better activity than the parent compound (Matrine) and positive control Cisplatin. Furthermore, the Annexin V-FITC/PI dual staining assay revealed that compound A6 and B21 could significantly induce the apoptosis of SMMC-7721 and CNE2 cells in a dose-dependent manner. The cell cycle analysis also revealed that compound A6 could cause cell cycle arrest of SMMC-7721 and CNE2 cells at G2/M phase.     

Ursolic acid benzaldehyde chalcone,leads to inhibition of cell proliferation and arrests cycle in G1/G0 phase in colon cancer

The present study investigates the effect of matrine on colon cancer cell viability and apoptosis and tumor growth in mice xenograft model. The results from MTT assay revealed a concentration and time dependent reduction in viability of HCT8 and HT29 colon cancer cells by matrine. The viability of HCT8 and HT29 cells was reduced to 24.67 and 29.32% on treatment with 4 µM/ml concentration of matrine after 48 h (P < 0.05). The results from flow cytometry revealed increase in population of HCT8 and HT29 cells to 77.6 ± 0.3 and 54.0 ± 5.4%, respectively compared to 1.4 ± 0.3 and 2.4 ± 0.7% in control on exposure to 1 µM/ml concentration of matrine. Histone H2AX phosphorylation and expression of Myt1, cyclin A2, cyclin B1 and p53 were increased in HCT8 and HT29 cells on treatment with matrine for 48 h. Matrine treatment also increased the phosphorylation of cdc2 significantly compared to control cells at 48 h (P < 0.05). Results from Annexin-V/FITC-staining showed increase in proportion of apoptotic cells in HCT8 and HT29 cells 67.52 and 68.56 on treatment with 1 µM/ml of matrine. Matrine treatment caused a marked reduction in the growth of HCT8 cell xenograft after 21 days. Thus matrine inhibits cell viability, induces apoptosis and inhibits tumor growth in colon cancer.     

苦参注射液与恩度联合顺铂对肺癌恶性胸腔积液患者血清炎症因子水平的影响

目的:探讨苦参注射液与恩度分别联合顺铂对肺癌恶性胸腔积液患者血清炎症因子水平影响。方法:收集我院以非小细胞肺癌合并恶性胸腔积液患者68例,按照就诊先后顺序分为实验组和对照组。对照组予恩度联合顺铂化疗,实验组予苦参注射液联合顺铂化疗。于患者治疗前后进行CD8~+、IL-2检测,KPS评分,并进行生活质量评价及胸腔积液疗效评价比较,以及药物不良反应评价。结果:1治疗后实验组CD8~+下降、IL-2均上升(P0.05);2治疗后实验组KPS评分较对照组明显上升(P0.05);3实验组患者生活质量评价明显好于对照组,胸腔积液疗效优于对照组(P0.05)。结论:苦参注射液联合顺铂较恩度联合顺铂对肺癌合并恶性胸腔积液患者CD8~+T淋巴细胞及IL-2水平有更明显调节作用,且安全性更佳,对肺癌合并恶性胸腔积有显著临床疗效,对提高患者生活质量、延长患者生存期有重要意义。     

苦参碱对胆囊癌患者血清及胆囊组织中MMP-7, p-STAT3及E-Cad 水平的影响

目的:探讨苦参碱对胆囊癌患者血清及胆囊组织中MMP-7,p-STAT3及E-Cad水平的影响。方法:收集我院治疗的60例胆囊癌患者,随机分为实验组和对照组,每组30例,患者均择日行胆囊癌标准根治术,实验组患者者在对照组患者基础上术后给予苦参碱胶囊治疗。观察并比较两组患者血清及胆囊组织中MMP-7,p-STAT3及E-Cad水平的变化情况,以及5年中位生存率。结果:与治疗前相比,治疗后两组患者血清及胆囊组织中MMP-7,p-STAT3及E-Cad水平均下降,差异具有统计学意义(P0.05);与对照组相比,实验组患者治疗后血清及胆囊组织中MMP-7,p-STAT3及E-Cad水平较低,差异具有统计学意义(P0.05);实验组患者5年中位生存月高于对照组,差异具有统计学意义(P0.05)。结论:苦参碱能够降低胆囊癌患者血清及胆囊组织中MMP-7,p-STAT3及E-Cad水平,延长生存时间,对临床具有指导意义。